Comparing two forms of an stomach acid drug
Part of Digestive system clinical trials.
This study compares how two different forms of a drug (AD-120 and AD-120A) move through the body and affect stomach acid levels. It is for healthy volunteers and helps researchers understand if a new version works similarly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 19 and 50 years old.
- Your weight must be between 110 and 198 pounds (50 to 90 kg).
- Your body mass index (BMI) must be between 18.5 and 29.9.
- You must test negative for Helicobacter pylori (a stomach bacteria).
- You must be able to tolerate a small tube (pH monitor) placed in your stomach.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug (AD-115A or AD-1151) in healthy volunteers to see how safe it is and how the body processes it. If you qualify, you'll receive a single dose and be monitored closely.
This trial tests two versions of the same drug to see if they work the same in the body. It's for healthy volunteers who are willing to follow strict guidelines about diet, exercise, and medications.
This trial tests three similar drugs to see how they are processed by the body and how safe they are. It is for healthy volunteers to help find the best dose and form of these medications.
This trial compares how the body processes two different forms of the same drug, AD-117 and AD-117A, and checks for safety. It's for healthy adults to help ensure the drug works similarly and safely.
This phase 1 trial tests a new medicine called IY-828026 in healthy volunteers to see how safe it is and how the body processes it. It's a first step to find the right dose and check for side effects.
This study tests two new experimental drugs, AD-118 and AD-1181, in healthy adults to see if they are safe and how the body processes them. It helps researchers decide if further testing in patients is possible.
Hear when a new Gastroesophageal Reflux Disease (GERD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.